Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Authors :: Heslop H
Rooney C
Brenner M
Krance R
Carrum G
Gahn B
Bollard C
Khan S
Gee A
Popat U
Gresik M
Przepiorka D
Kuehnle I
Grilley B
Source :: Human gene therapy [Hum Gene Ther] 2000 Jul 01; Vol. 11 (10), pp. 1465-75.
Publication Year :: 2000

Subjects :: Cell Line
Feasibility Studies
Female
Herpesvirus 4, Human immunology
Humans
Male
Recurrence
Bone Marrow Transplantation methods
Drug Resistance, Neoplasm genetics
Genetic Therapy
Herpesvirus 4, Human genetics
Hodgkin Disease therapy
Neomycin metabolism
T-Lymphocytes, Cytotoxic metabolism

Full Text Access

Tools